GFP
GILD icon

Gryphon Financial Partners’s Gilead Sciences GILD Stock Holding History

Gryphon Financial Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$826K Buy
6,540
+472
+8% +$62.2K 0.07% 172
2026
Q1 		$846K Buy
6,068
+1,140
+23% +$160K 0.09% 155
2025
Q4 		$605K Buy
4,928
+534
+12% +$64.9K 0.06% 190
2025
Q3 		$488K Buy
4,394
+2,407
+121% +$274K 0.06% 199
2025
Q2 		$220K Buy
1,987
+115
+6% +$12.2K 0.03% 287
2025
Q1 		$210K Buy
+1,872
New +$193K 0.03% 272
2020
Q2 		– Sell
-22,306
Closed -$1.67M – 146
2020
Q1 		$1.67M Buy
22,306
+387
+2% +$26.7K 0.61% 25
2019
Q4 		$1.42M Sell
21,919
-155
-0.7% -$10.1K 0.37% 35
2019
Q3 		$1.4M Buy
22,074
+417
+2% +$27.3K 0.4% 34
2019
Q2 		$1.46M Buy
21,657
+1,292
+6% +$85K 0.42% 30
2019
Q1 		$1.32M Sell
20,365
-3,300
-14% -$219K 0.39% 31
2018
Q4 		$1.48M Sell
23,665
-1,678
-7% -$117K 0.38% 50
2018
Q3 		$1.96M Buy
25,343
+200
+0.8% +$15.1K 0.58% 22
2018
Q2 		$1.78M Sell
25,143
-292
-1% -$20.6K 0.8% 16
2018
Q1 		$1.92M Sell
25,435
-217
-0.8% -$17.3K 0.98% 16
2017
Q4 		$1.84M Buy
+25,652
New +$1.95M 1.05% 14

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gryphon Financial Partners's GILD Position: Q2 2026 in Review

Gryphon Financial Partners increased its Gilead Sciences (GILD) stake by 7.8% in Q2 2026, buying an estimated $62.2K and bringing the position to 6,540 shares worth $826K. The position accounts for 0.07% of the portfolio, ranked #172.

Gryphon Financial Partners first reported a position in GILD in Q4 2017 and has held it in 16 quarters since. The position peaked at $1.96M in Q3 2018. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Gryphon Financial Partners held 6,540 shares of Gilead Sciences worth $826K as of Q2 2026.
  • Gryphon Financial Partners bought 472 Gilead Sciences shares in Q2 2026, an estimated $62.2K.
  • Gilead Sciences made up 0.07% of Gryphon Financial Partners's portfolio in Q2 2026, its #172 holding.
  • Gryphon Financial Partners first reported a position in Gilead Sciences in Q4 2017 and has held it in 16 quarters since.
  • Gryphon Financial Partners's Gilead Sciences position peaked at $1.96M in Q3 2018.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.